Detalle Publicación

ARTÍCULO
High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevencion con Dieta Mediterranea (PREDIMED) Study
Autores: Papandreou, C.; Hernandez-Alonso, P.; Bullo, M.; Ruiz-Canela, Miguel; Li, J.; Guasch-Ferre, M.; Toledo Atucha, Estefanía; Clish, C.; Corella, D.; Estruch, R.; Cofan, M.; Fito, M.; Razquin, C.; Aros, F.; Fiol, M.; Santos-Lozano, J. M.; Serra Majem, L.; Liang, L. M.; Martínez González, Miguel Ángel; Hu, F. B.; Salas Salvado, J.
Título de la revista: JOURNAL OF NUTRITION
ISSN: 0022-3166
Volumen: 150
Número: 11
Páginas: 2882 - 2889
Fecha de publicación: 2020
Lugar: WOS
Resumen:
Background: Although the association between glutamate and glutamine in relation to cardiometabolic disorders has been evaluated, the role of these metabolites in the development of atrial fibrillation (AF) and heart failure (HF) remains unknown. Objectives: We examined associations of glutamate, glutamine, and the glutamine-to-glutamate ratio with AF and HF incidence in a Mediterranean population at high cardiovascular disease (CVD) risk. Methods: The present study used 2 nested case-control studies within the PREDIMED (Prevencion con Dieta Mediterranea) study. During similar to 10 y of follow-up, there were 509 AF incident cases matched to 618 controls and 326 HF incident cases matched to 426 controls. Plasma concentrations of glutamate and glutamine were semiquantitatively profiled with LC-tandem MS. ORs were estimated with multivariable conditional logistic regression models. Results: In fully adjusted models, per 1-SD increment, glutamate was associated with a 29% (95% CI: 1.08, 1.54) increased risk of HF and glutamine-to-glutamate ratio with a 20% (95% CI: 0.67, 0.94) decreased risk. Glutamine-to-glutamate ratio was also inversely associated with HF risk (OR per 1-SD increment: 0.80; 95% CI: 0.67, 0.94) when comparing extreme quartiles. Higher glutamate concentrations were associated with a worse cardiometabolic risk profile, whereas a higher glutamine-to-glutamate ratio was associated with a better cardiometabolic risk profile. No associations between the concentrations of these metabolites and AF were observed. Conclusions: Our findings suggest that high plasma glutamate concentrations possibly resulting from alterations in the glutamate-glutamine cycle may contribute to the development of HF in Mediterranean individuals at high CVD risk.